Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best biotech stocks with high potential. In a report released on ...
The Bakersfield Californian

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman

SAN FRANCISCO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report ...
Nasdaq

SOLENO THERAPEUTICS Earnings Results: $SLNO Reports Quarterly Earnings

SOLENO THERAPEUTICS ($SLNO) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of -$0.95 per share, missing estimates of -$0.95 by ...

Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best strong buy stocks to invest in according to Wall Street. On ...
Business Wire

Soleno Therapeutics, Inc. (SLNO) Under Investigation After Scorpion Capital Report Raises Drug Safety Concerns; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Soleno Therapeutics, Inc. (“Soleno”) fell over 12% on September 10, 2025, after the company disclosed a patient death involving its treatment for ...
Nasdaq

Soleno Therapeutics, Inc. (SLNO) Reports Q2 Loss, Tops Revenue Estimates

Soleno Therapeutics, Inc. (SLNO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.57 per share a year ago. These ...
Morningstar

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report — Hagens Berman

SAN FRANCISCO, Aug. 20, 2025 /PRNewswire/ -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report by ...